Carson Advisory’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Hold |
29,570
| – | – | 0.02% | 171 |
|
|
2025
Q1 | $47K | Buy |
29,570
+4,900
| +20% | +$7.79K | 0.03% | 164 |
|
|
2024
Q4 | $74.8K | Buy |
24,670
+100
| +0.4% | +$303 | 0.05% | 157 |
|
|
2024
Q3 | $90.4K | Buy |
24,570
+8,800
| +56% | +$32.4K | 0.06% | 177 |
|
|
2024
Q2 | $64.5K | Buy |
15,770
+3,000
| +23% | +$12.3K | 0.05% | 166 |
|
|
2024
Q1 | $201K | Buy |
+12,770
| New | +$201K | 0.14% | 164 |
|